Soligenix (SNGX) Return on Sales (2010 - 2024)
Soligenix's (SNGX) quarterly Return on Sales came in at 0.73% in Q4 2024, down 65.0% YoY from 2.08% in Q1 2024, and down 272.84% on a QoQ basis from 0.19% in Q3 2024.
Soligenix (SNGX) Return on Sales (2010 - 2024) Analysis & Trends
Soligenix (SNGX) has 15 years of Return on Sales data on file, last reported at 0.73% in Q4 2024.
- Quarterly Return on Sales fell 65.0% year-over-year to 0.73% in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 0.73% (down 65.0% YoY) and the FY2024 annual result came in at 0.69%, down 62.0% from the prior year.
- Return on Sales fell to 0.73% in Q4 2024, from 0.19% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.03% in Q3 2020 to a low of 7.02% in Q2 2024.
- A 5-year average of 0.49% and a median of 0.12% in 2022 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2023 — Return on Sales advanced 19 bps — and 2024, when it tumbled 694 bps.
- Tracing SNGX's Return on Sales over 5 years: stood at 0.09% in 2020, then plunged by 91 bps to 0.17% in 2021, then surged by 40 bps to 0.1% in 2022, then climbed by 28 bps to 0.07% in 2023, then tumbled by 878 bps to 0.73% in 2024.
- The last three Return on Sales figures came in at 0.73% (Q4 2024), 0.19% (Q3 2024), and 7.02% (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | Soligenix | 6.45 Mn | 6.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -0.73% |
| Sep 30, 2024 | -0.19% |
| Jun 30, 2024 | -7.02% |
| Mar 31, 2024 | -0.16% |
| Dec 31, 2023 | -0.07% |
| Sep 30, 2023 | -0.13% |
| Jun 30, 2023 | -0.08% |
| Mar 31, 2023 | -0.04% |
| Dec 31, 2022 | -0.10% |
| Sep 30, 2022 | -0.13% |
| Jun 30, 2022 | -0.10% |
| Mar 31, 2022 | -0.23% |
| Dec 31, 2021 | -0.17% |
| Sep 30, 2021 | -0.15% |
| Jun 30, 2021 | -0.09% |
| Mar 31, 2021 | -0.16% |
| Dec 31, 2020 | -0.09% |
| Sep 30, 2020 | -0.03% |
| Jun 30, 2020 | -0.05% |
| Mar 31, 2020 | -0.08% |